Mode
Text Size
Log in / Sign up
Phase 4 N=100 Randomized Treatment

Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty

Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty

Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Jul 2021
Primary outcome: Primary: Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS) — 30.2; 40.7 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
diclofenac (Drug); Norco (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Jul 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)
17.2; 18.9
SECONDARY
Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)
17.2; 18.9
SECONDARY
Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)
17.2; 18.9
SECONDARY
Pain Score as Assessed by a 100mm Visual Analogue Scale (VAS)
17.2; 18.9
SECONDARY
Number of Participants With Bleeding Complications
0; 0
SECONDARY
Number of Participants With Constipation
SECONDARY
Number of Participants With Nausea or Vomiting

Summary

The purpose of this study is to compare the level of pain control in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.

Eligibility Criteria

Inclusion Criteria

  • english speaking
  • candidates for endoscopic sinus surgery as determined by medical necessity by the treating rhinologist
  • scheduled for surgery at Texas Sinus Institute

Exclusion Criteria

  • allergy to either NSAIDs or opioids
  • contraindication to NSAIDs (ex. gastritis, chronic kidney disease)
  • surgical plan exceeding basic endoscopic sinus surgery
  • use of anticoagulation
  • the presence of any pain disorder
  • the current usage of any analgesic medication
  • history of opioid addiction
  • pregnancy
  • history of chronic pain or fibromyalgia
  • current daily use of NSAIDs, acetaminophen, opioids or other analgesics (pregabalin, tramadol, etc)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03605914). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search